Ramdev Gets Delhi High Court Relief In 'Rooh Afza' Remark Row
New Delhi:
In a relief for yoga guru Ramdev, the Delhi High Court has closed a lawsuit against him. The court passed the order while hearing a case filed by the Hamdard National Foundation India against Ramdev and his Patanjali Foods Ltd over a controversial remark. This comes weeks after the court said Ramdev's "sharbat jihad" remark against Hamdard's 'Rooh Afza' was "indefensible".
Hamdard has claimed that Ramdev, in videos to promote Patanjali's "gulab sharbat", alleged that the money earned from Hamdard's 'Rooh Afza' - a concentrated squash - was used to construct madrasas and mosques.
Today, the Delhi High Court was informed that Ramdev has filed an affidavit, undertaking that the videos against Rooh Afza have been taken down.
Ramdev's counsel informed the court that the affidavit, in compliance with judicial orders, has been tendered by Ramdev and Patanjali.
The court sought an affidavit from them on April 22, assuring "not to issue any statements, social media posts or disparaging videos/advertisements in future similar to those which are subject matter of the present suit in respect of products of the competitors." The court also said Ramdev's "sharbat jihad" remark on Hamdard's Rooh Afza was "indefensible" and "shook its conscience".
The case was closed after senior advocate Sandeep Sethi, appearing for Hamdard, did not press for any other relief in the suit.
On May 1, after the court warned of initiating contempt action against Ramdev, his lawyer assured that certain objectionable content, which was subsequently published, would also be deleted within 24 hours.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
Delhi HC to DPS, Dwarka: Using bouncers to block students' entry over fees is ‘mental harassment'
New Delhi: Expressing strong disapproval of Delhi Public School, Dwarka's conduct in allegedly deploying bouncers to block students' entry over a fee dispute, Delhi High Court on Thursday termed the act of publicly shaming students for non-payment of fees as "mental harassment". A single-judge bench of Justice Sachin Datta remarked, "This court is constrained to express its dismay at the alleged conduct of the petitioner school in engaging "bouncers" to physically block the entry of certain students into the school premises. Such a reprehensible practice has no place in an institute of learning. It reflects not only a disregard for the dignity of a child but also a fundamental misunderstanding of a school's role in society. " The court was hearing a petition filed by parents of students who had been expelled last month for non-payment of fees. It was informed that the school later withdrew its expulsion orders following a directive from a coordinate bench, reinstating the affected students. The court emphasised that any form of public shaming or intimidation over financial issues, especially using force or coercive means, constitutes mental harassment and undermines a child's psychological well-being. "The use of bouncers fosters a climate of fear, humiliation, and exclusion, which is incompatible with the ethos of education," the bench stated. While noting that the school is entitled to charge reasonable for its operations—to sustain infrastructure, remunerate staff, and provide a conducive learning environment—the court underlined that an educational institution cannot be equated with a commercial enterprise. "The driving force of a school—especially one managed by a reputed society—must be public welfare, nation-building, and holistic child development, not profit maximisation. The primary objective of a school is to impart education and inculcate values, not to operate as a business enterprise," the court observed. As the school had reinstated the students, the court said the petition had become largely moot. However, it directed that any future action under Rule 35 of the Delhi School Education Rules, 1973, must be preceded by proper notice and an opportunity for the affected students or their guardians to respond.
Hindustan Times
8 hours ago
- Hindustan Times
Late by 6 minutes for test, student's plea fails to convince Delhi HC
New Delhi, The Delhi High Court has refused relief to a student who missed the Common University Entrance Test by six minutes outlining the "sanctity and discipline" of examinations. The 18-year-old candidate claimed on May 13 she reached the exam center at around 8.36 am six minutes beyond the scheduled time of the test but was denied entry. A bench of Justices Prathiba M Singh and Rajneesh Kumar Gupta was hearing her plea against a single judge's order declining to intervene in the matter. The bench observed that the information bulletin of the National Testing Authority and the admit card gave very specific instructions on reaching the centre at around 7 am, two hours prior to the commencement of the examination, as gates would shut at around 8.30 am. The bench said leniency in the conduct of such a large-scale examination would lead to chaos and "discipline of the examination ought to be maintained". "The CUET is an important entrance examination and the discipline in arriving at the examination hall in time, taking the seat in time and being at the center before the gate closing time, are all part of the discipline and ethos of the examination ecosystem which ought not to be relaxed, inasmuch as, the same may lead to huge inequities between similarly placed students," the court held on May 31. The bench dismissed her appeal and said, "One might feel that it was only a matter of six minutes, but the authorities could not be blamed for enforcing the rule of gate closing timings strictly and discrimination was not a valid ground to interfere." Being "extremely conscious" of the negative impact on the student's career, the court said it could not lose sight of the discipline required to be maintained in such examinations. "The CUET UG examination is an exam where more than 13.54 lacs students from across the country appear. If exceptions are made, and discipline is not followed in such an exam, the timely conduct of the exam, the timely announcement of results and timely admission to colleges and Universities is all likely to be jeopardised and there would be a cascading effect. In such matters, the interference by the Court should be the least ," it stated.
Mint
10 hours ago
- Mint
How Medikabazaar's new CEO is trying to turn around the business, target profitability this year
Medikabazaar, the medical equipment supplier, expects to put the controversies surrounding the startup behind it as it targets profitability this year, CEO Dinesh Lodha told Mint in an exclusive interview. The startup, which is entangled in legal disputes, has started exports and is expanding its portfolio offerings to drive growth. Lodha, who was appointed group CEO in August 2024, said the business is turning around and that will help rebuild confidence among its investors and customers. 'This is the third quarter going on, [since] I joined, and in the last two quarters there are significant changes happening in the business. We have cut down our loss by 80% by quarter four from quarter one," he told Mint. 'In Q4 we ended up at a revenue run rate of ₹2,200 crore, with some losses. Next year, we're looking at a run rate of ₹3,200 crore by Q4FY26, with Ebitda profitability. For the first time the company will show a solid profitability and a good cash flow." Lodha said his mandate is to run the business and that the dispute between investors is not a distraction. 'The team is very focused. And my approach is also very focused," said Lodha. 'The way things are getting turned around, I think people are getting more and more confident. We are not losing customers because of this." The Mumbai-based B2B medical supply chain platform has been mired in controversy and legal disputes following a whistleblower complaint in December 2023 accusing the then-senior management of round-tripping of accounts to inflate revenue and other irregularities. The allegations have been validated by forensic audits. The company's auditor resigned, its FY23 financials were restated, and its leadership was overhauled. Founder's ouster Co-founder Vivek Tiwari stepped down as chief executive officer in July 2024 to take on a board role. He was then ousted by the company's board in April 2025 over allegations of malicious and fraudulent activities, including financial mismanagement and financial fraud. Tiwari is fighting cases in multiple jurisdictions, including the Delhi High Court and the National Company Law Tribunal. In an earlier interview to Mint, he denied allegations of financial misreporting. Also Read | Medikabazaar's ousted CEO denies board's allegations of financial irregularities Additionally, the company's Series C investors including Creagis, CDC Group, HealthQuad and Ackermans & van Haaren, filed an indemnity claim, or compensation, of ₹279 crore against the company over allegations of financial misreporting. Lodha comes with over two decades of experience in the healthcare and medtech space, having previously worked as group CEO at Healthium Medtech, country head for Samsung's healthcare vertical, and sales director at GE Healthcare. He has 'a proven track record of leading successful turnarounds of businesses," according to his LinkedIn profile. Medikabazaar reported a gross operating revenue of ₹1,355.5 crore in FY24, a 50% surge from the preceding year, according to Entrackr. Its loss widened by 30% to ₹394.8 crore. The company's expansion is driven by adding new growth segments and an internal clean-up with a focus on transparency. 'If you ask me one word in this organisation which I've tried to change, it is to 'empower' the people to take decisions, but then be accountable," he said. The company has had a good retention of its leadership, employees and customers over the past 18 months, Lodha said. 'That itself gives you confidence that things are pretty much solid in place," Lodha said. 'We have added many new segments, new leaders. But we retain the core," he added. Exports to drive growth Lodha is driving the company's expansion beyond Indian shores. The company is already facilitating Indian manufacturers with certification to export to countries in the Middle East, Africa, some parts of Asia, and South America. 'It is in the early stages… but it is a huge, significant growth area for us as we go forward. At this point of time, export [segment] is not that significant. We are talking 5-6% of our business. But that will significantly grow to 15-20% as we go forward," Lodha said. Also Read | The fallout of an audit and missed targets: Medikabazaar founders set to lose stock options Medikabazaar is a B2B seller for medical equipment and drugs, including consumables such as surgical gloves, devices like MRI machines, and vaccines. It has over 400,000 customers through its digital marketplace and has tied up with over 1,000 hospitals in the country. The company has also started its own brand called MB+ for medical consumables, pharmaceuticals, and vaccines that it will directly offer to customers, which is a high-margin business and will form a significant chunk of the company's revenue, said Lodha. It is targeting tier-2 and tier-3 hospitals and aims to offer complete supply chain and procurement solutions to at least 100-150 hospitals in the next 12-14 months. 'In India, nobody has the portfolio breadth that we have with presence in equipment and devices, consumables, disposables, IVD (in vitro diagnostics) and pharma," said Lodha. 'We offer a one-stop solution in all procurement segments… that's a very big opportunity for hospitals to really work with one company as a single-window procurement partner rather than working with, say, 200 distributors." Medikabazaar competes with large manufacturers in individual segments such as medical equipment companies Wipro GE Healthcare and Medtronic, as well as other B2B marketplaces MedDeal and Zoplar. Also Read | Indian medtech's just coming of age, and already has global ambitions Medikabazaar has raised $165 million (about ₹1,380 crore) via debt and equity to date. It was reportedly in talks to raise $150-200 million last year, which did not materialise after the forensic audit. Lodha said that the company is not looking at raising funds currently and that it built a good cash flow in Q4. 'We are continuing to be focused on cash flow," he said. 'Wherever the investment is required, I think the existing investors [are] very bullish on the business… they are ready to fund it further."
